Port Erin Biopharma Investments Limited
("Port Erin" or the "Company")
Director's Dealing
Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that the Chairman, Jim Mellon, purchased 744,000 Ordinary Shares at an average price of 8.23 pence per share on 6th February 2013. The Company was further informed that Galloway Limited had acquired 1,000,000 Ordinary Shares at a price of 6.00 pence per share on 5th February, 2013.
Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a Director of Galloway Limited.
Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 6,760,000 representing 20.5% of the issued ordinary share capital of the Company.
Enquiries:
|
Port Erin Biopharma Investments Limited |
|||
|
Denham Eke |
(+44) 1624 639396 |
||
|
Libertas Capital Corporate Finance Limited |
|||
|
Sandy Jamieson |
(+44) 20 7569 9650 |
||
|
Rivington Street Corporate Finance Limited |
|||
|
John Levinson |
(+44) 20 7562 3350 |
||
This information is provided by RNS